rac-N-(3,5-Dichlorophenyl)-4-(pyridin-4-yl)-6,7-dihydrothieno-[3,2-c]pyridine-5(4H)-carboxamide

ID: ALA4573451

PubChem CID: 155563505

Max Phase: Preclinical

Molecular Formula: C19H15Cl2N3OS

Molecular Weight: 404.32

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(Nc1cc(Cl)cc(Cl)c1)N1CCc2sccc2C1c1ccncc1

Standard InChI:  InChI=1S/C19H15Cl2N3OS/c20-13-9-14(21)11-15(10-13)23-19(25)24-7-3-17-16(4-8-26-17)18(24)12-1-5-22-6-2-12/h1-2,4-6,8-11,18H,3,7H2,(H,23,25)

Standard InChI Key:  RFTDOKATMJAJBE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   25.1056  -15.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8183  -15.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8183  -14.3880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.1056  -13.9710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1061  -13.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8229  -12.7339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8233  -11.9088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1075  -11.4952    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3901  -11.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3932  -12.7361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3930  -15.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3930  -14.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6034  -14.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1152  -14.7986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6033  -15.4704    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.5346  -13.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2485  -14.3923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5371  -13.1515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9649  -13.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6755  -14.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3914  -13.9900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3942  -13.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6753  -12.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9623  -13.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1050  -14.4053    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.6748  -11.9228    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
  3 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 23 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4573451

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 404.32

Molecular Weight (Monoisotopic): 403.0313

AlogP: 5.63

#Rotatable Bonds: 2

Polar Surface Area: 45.23

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.74

CX Basic pKa: 5.00

CX LogP: 4.78

CX LogD: 4.78

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.60

Np Likeness Score: -2.05

References

1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G..  (2019)  Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.,  62  (22): [PMID:31670515] [10.1021/acs.jmedchem.9b01382]

Source

Source(1):

• Scientific Literature